Eisele Jeffrey
CIK 0001827326Chief Development Officer
Filings
5
Latest Jan 31, 2024
Issuers covered
1
Showing
5 of 5
Page 1
Issuers
Companies where Eisele Jeffrey has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | 5 | Jan 31, 2024 |
All filings
5 Form 4 / 4-A filings, newest first
| Filed | Issuer | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Jan 31, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 971 | $65.53 | $63,630 | |
| Jan 24, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 7,378 | $63.69 | $469,905 | |
| Jan 23, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 1,607 | $64.996 | $104,449 | |
| Jan 18, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 5,207 | $65.58 | $341,475 | |
| Jan 17, 2024 | APLSApellis Pharmaceuticals, Inc. | S | 438 | $66.8086 | $29,262 |
Showing 1–5 of 5
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.